A new study tested risankizumab in patients with severe asthma and found it worsened their asthma symptoms.

Today, Oct. 29, 2021, is World Psoriasis Day. To mark the day the IFPA (an international federation of psoriatic disease associations) is...

According to a new study, hepatitis C virus infection is linked to an increased risk for chronic inflammatory skin diseases.

A new study suggests that the use of biologics in patients with inflammatory skin diseases is safe during the Covid-19 pandemic.

A study in the British Journal of Dermatology appears to show that alcohol misuse can be associated with poor response to systemic...

New research has suggested that the levels of interferon kappa, a skin protein, may be linked to the severity of psoriasis.

A recent evaluation of studies on the risk of Covid-19 in patients with psoriasis and psoriatic arthritis has suggested a high risk of bias.

Study results indicate that maintenance doses of bimekizumab (320 mg) every four or eight weeks can maintain high levels of skin...